381 related articles for article (PubMed ID: 33422642)
1. Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
Al-Abdouh A; Bizanti A; Barbarawi M; Jabri A; Kumar A; Fashanu OE; Khan SU; Zhao D; Antar AAR; Michos ED
Contemp Clin Trials; 2021 Feb; 101():106272. PubMed ID: 33422642
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials.
Izcovich A; Siemieniuk RA; Bartoszko JJ; Ge L; Zeraatkar D; Kum E; Qasim A; Khamis AM; Rochwerg B; Agoritsas T; Chu DK; McLeod SL; Mustafa RA; Vandvik P; Brignardello-Petersen R
BMJ Open; 2022 Mar; 12(3):e048502. PubMed ID: 35236729
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
Piscoya A; Ng-Sueng LF; Parra Del Riego A; Cerna-Viacava R; Pasupuleti V; Roman YM; Thota P; White CM; Hernandez AV
PLoS One; 2020; 15(12):e0243705. PubMed ID: 33301514
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials.
Lai CC; Chen CH; Wang CY; Chen KH; Wang YH; Hsueh PR
J Antimicrob Chemother; 2021 Jul; 76(8):1962-1968. PubMed ID: 33758946
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.
Singh S; Khera D; Chugh A; Khera PS; Chugh VK
BMJ Open; 2021 Jun; 11(6):e048416. PubMed ID: 34168031
[TBL] [Abstract][Full Text] [Related]
6. Remdesivir for Adults With COVID-19 : A Living Systematic Review for American College of Physicians Practice Points.
Wilt TJ; Kaka AS; MacDonald R; Greer N; Obley A; Duan-Porter W
Ann Intern Med; 2021 Feb; 174(2):209-220. PubMed ID: 33017170
[TBL] [Abstract][Full Text] [Related]
7. Remdesivir for the treatment of COVID-19: a living systematic review.
Verdugo-Paiva F; Acuña MP; Solá I; Rada G;
Medwave; 2020 Dec; 20(11):e8080. PubMed ID: 33361753
[TBL] [Abstract][Full Text] [Related]
8. Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis.
Rezagholizadeh A; Khiali S; Sarbakhsh P; Entezari-Maleki T
Eur J Pharmacol; 2021 Apr; 897():173926. PubMed ID: 33549577
[TBL] [Abstract][Full Text] [Related]
9. Major Update: Remdesivir for Adults With COVID-19 : A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points.
Kaka AS; MacDonald R; Greer N; Vela K; Duan-Porter W; Obley A; Wilt TJ
Ann Intern Med; 2021 May; 174(5):663-672. PubMed ID: 33560863
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials.
Gebrie D; Getnet D; Manyazewal T
BMJ Open; 2020 Jun; 10(6):e039159. PubMed ID: 32503874
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
Trials; 2020 May; 21(1):422. PubMed ID: 32448345
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
Tasavon Gholamhoseini M; Yazdi-Feyzabadi V; Goudarzi R; Mehrolhassani MH
J Pharm Pharm Sci; 2021; 24():237-245. PubMed ID: 34048669
[TBL] [Abstract][Full Text] [Related]
14. Drug treatments for covid-19: living systematic review and network meta-analysis.
Siemieniuk RA; Bartoszko JJ; Zeraatkar D; Kum E; Qasim A; Martinez JPD; Izcovich A; Lamontagne F; Han MA; Agarwal A; Agoritsas T; Azab M; Bravo G; Chu DK; Couban R; Devji T; Escamilla Z; Foroutan F; Gao Y; Ge L; Ghadimi M; Heels-Ansdell D; Honarmand K; Hou L; Ibrahim Q; Khamis A; Lam B; Mansilla C; Loeb M; Miroshnychenko A; Marcucci M; McLeod SL; Motaghi S; Murthy S; Mustafa RA; Pardo-Hernandez H; Rada G; Rizwan Y; Saadat P; Switzer C; Thabane L; Tomlinson G; Vandvik PO; Vernooij RW; Viteri-García A; Wang Y; Yao L; Zhao Y; Guyatt GH; Brignardello-Petersen R
BMJ; 2020 Jul; 370():m2980. PubMed ID: 32732190
[TBL] [Abstract][Full Text] [Related]
15. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
Ader F; Bouscambert-Duchamp M; Hites M; Peiffer-Smadja N; Poissy J; Belhadi D; Diallo A; Lê MP; Peytavin G; Staub T; Greil R; Guedj J; Paiva JA; Costagliola D; Yazdanpanah Y; Burdet C; Mentré F;
Lancet Infect Dis; 2022 Feb; 22(2):209-221. PubMed ID: 34534511
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis.
Elsawah HK; Elsokary MA; Abdallah MS; ElShafie AH
Rev Med Virol; 2021 Jul; 31(4):e2187. PubMed ID: 33128490
[TBL] [Abstract][Full Text] [Related]
17. Use of remdesivir in patients with COVID-19: a systematic review and meta-analysis.
Tanni SE; Silvinato A; Floriano I; Bacha HA; Barbosa AN; Bernardo WM
J Bras Pneumol; 2022; 48(1):e20210393. PubMed ID: 35137874
[TBL] [Abstract][Full Text] [Related]
18. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD; Gottlieb RL; Criner GJ; Arribas López JR; Cattelan AM; Soriano Viladomiu A; Ogbuagu O; Malhotra P; Mullane KM; Castagna A; Chai LYA; Roestenberg M; Tsang OTY; Bernasconi E; Le Turnier P; Chang SC; SenGupta D; Hyland RH; Osinusi AO; Cao H; Blair C; Wang H; Gaggar A; Brainard DM; McPhail MJ; Bhagani S; Ahn MY; Sanyal AJ; Huhn G; Marty FM;
JAMA; 2020 Sep; 324(11):1048-1057. PubMed ID: 32821939
[TBL] [Abstract][Full Text] [Related]
19. Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial.
Ali K; Azher T; Baqi M; Binnie A; Borgia S; Carrier FM; Cavayas YA; Chagnon N; Cheng MP; Conly J; Costiniuk C; Daley P; Daneman N; Douglas J; Downey C; Duan E; Duceppe E; Durand M; English S; Farjou G; Fera E; Fontela P; Fowler R; Fralick M; Geagea A; Grant J; Harrison LB; Havey T; Hoang H; Kelly LE; Keynan Y; Khwaja K; Klein G; Klein M; Kolan C; Kronfli N; Lamontagne F; Lau R; Fralick M; Lee TC; Lee N; Lim R; Longo S; Lostun A; MacIntyre E; Malhamé I; Mangof K; McGuinty M; Mergler S; Munan MP; Murthy S; O'Neil C; Ovakim D; Papenburg J; Parhar K; Parvathy SN; Patel C; Perez-Patrigeon S; Pinto R; Rajakumaran S; Rishu A; Roba-Oshin M; Rushton M; Saleem M; Salvadori M; Scherr K; Schwartz K; Semret M; Silverman M; Singh A; Sligl W; Smith S; Somayaji R; Tan DHS; Tobin S; Todd M; Tran TV; Tremblay A; Tsang J; Turgeon A; Vakil E; Weatherald J; Yansouni C; Zarychanski R; ;
CMAJ; 2022 Feb; 194(7):E242-E251. PubMed ID: 35045989
[TBL] [Abstract][Full Text] [Related]
20. The effects of remdesivir on mortality and the requirement for mechanical ventilation in patients with COVID-19: a systematic review stratified by disease severity.
Ryoo S; Choi M; Yu SY; Yoon YK; Huh K; Joo EJ
Korean J Intern Med; 2024 Jan; 39(1):160-171. PubMed ID: 38151918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
